Redox

Redox Named to the 2020 CB Insights Digital Health 150 List of Most Promising Digital Health Startups

Posted August 14, 2020
By Redox

For the second consecutive year, Redox recognized for advancements in interoperability

CB Insights today named Redox, the largest cloud-based interoperability provider, to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. 

“Being positioned among the top innovative digital health companies worldwide is a testament to the invaluable work Redox is doing to create the integration capabilities software developers need to navigate data exchange and interoperability in healthcare,” said Luke Bonney, CEO, Redox. “Redox standardizes healthcare data with a modern application programming interface (API), single point of integration and reusable network approach that powers applications that improve healthcare.”

“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year’s class of the best in digital health.”  

“Redox has become the de facto standard in healthcare cloud integration,” added Bonney. “Using the Redox Rapid Deployment Model, remote patient monitoring and telehealth software vendors can go live and integrate with healthcare organizations in less than two weeks, a process that typically takes 16-18 weeks. Over the past few months alone, Redox has seen a 46 percent increase in virtual care customers to our network.”

Quick facts on the 2020 Digital Health 150:

Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum. 

The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others. 

View the full list of CB Insights Digital Health 150 Companies now!


About CB Insights

At CB Insights, we believe the most complex strategic business questions are best answered with facts.  We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.

About Redox

Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange healthcare data. With just one connection, data can be transmitted across a growing network of more than 800 healthcare delivery organizations and 250 independent software vendors. Members of the Redox Network exchange more than 10 million patient records per day, leveraging a single data standard compatible with more than 50 electronic health record systems. Learn how you can leverage the Redox Platform at www.redoxengine.com. Please follow us on Twitter and LinkedIn.